Skip to content
  • Tuesday, 29 September 2026
  • 6:52 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Chiesi Acquires KalVista Pharmaceuticals for $1.9 Billion, Bolstering Rare Disease Portfolio with On-Demand HAE Treatment
Pharmaceutical R&D

Chiesi Acquires KalVista Pharmaceuticals for $1.9 Billion, Bolstering Rare Disease Portfolio with On-Demand HAE Treatment

Teuku Ryan May 3, 2026 0

In a landmark move that marks the largest acquisition in its 90-year history, Italian pharmaceutical giant Chiesi has agreed to…

Read More
Turning Plastic Waste into Clean Energy The Global Shift Toward Solar Powered Chemical UpcyclingLeveraging Mimesis for Secure Data Science: A Comprehensive Guide to Anonymizing Production Data.Boehringer Ingelheim eyes MASH as the next front for survodutide, a GLP-1/glucagon receptor dual agonistInflammation turns bone marrow into a breeding ground for disease
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteinsBreakthrough Brain Imaging Study Links Long COVID to Dopamine Neuron DamageAustrian Physicists Bridge Quantum Computing and Electron Microscopy to Revolutionize Atomic-Scale ImagingNovo Nordisk Expands Cardiometabolic Portfolio With $2.3bn Hengrui Licensing Deal for Once-Weekly Oral GLP-1/GIP Agonist HRS-1596
YOU MAY HAVE MISSED
Biotech & Genetic Research
The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins
Jia Lissa Sep 29, 2026
Neuroscience & Brain Research
Breakthrough Brain Imaging Study Links Long COVID to Dopamine Neuron Damage
Rifan Muazin Sep 29, 2026
Advanced Materials Science
Austrian Physicists Bridge Quantum Computing and Electron Microscopy to Revolutionize Atomic-Scale Imaging
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Novo Nordisk Expands Cardiometabolic Portfolio With $2.3bn Hengrui Licensing Deal for Once-Weekly Oral GLP-1/GIP Agonist HRS-1596
Teuku Ryan Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ